All treatments
Treatment
AMINOHIPPURIC ACID clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
This study is looking at how a medicine called Kerendia (finerenone) affects the kidneys in people with type 2 diabetes. It aims to see if Kerendia can help improve kidney function by reducing stress on kidney blood vessels, compared to a dummy pill.
For: type 2 diabetes mellitusGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
Rescue Therapy with the Human Anti-CD38 Antibody MOR202 (felzartamab) in Patients with Membranous Nephropathy who Failed Anti-CD20 Target Therapy (MONET study)
This study looks at a new medicine called felzartamab for people with a kidney condition called membranous nephropathy, who haven't improved with other treatments. It aims to see if the new medicine can reduce protein in their urine and help their kidneys get better.
For: Membranous nephropathyItaly